Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In vivo CUDC-101 promotes tumor regression in various cancer xenograft models such as non-small cell lung cancer (NSCLC)
PF 1022A (1-100 μg/mL) completely inhibits larval movement at most examination points
AMD 3465 treatment stimulates the phosphorylation of Erk1/2 in U87 and Daoy cells
proliferation of the tumors in HCT116 xenografts
ISX9 - Neurogenic Modulator. CAS# 832115-62-5 0249 In vivo CUDC-101 promotes tumorISX9, CAS No. 832115 62 5, is a neurogenic modulator. It mediates neuroD reporter gene induction via activation of Ca2+ influx, and increases expression of neurogenic differentiation 1 (NeuroD1) transcription factor. It induces neuronal differentiation in human cortical neuronal cells (HCN), adult mouse whole brain (MWB) and subventricular zone (SVZ) progenitors. ISX9 is also shown to induce cardiomyogenic differentiation of Notch activated epicardium
US$ 106.50
US$ 311.50
US$ 262.50
US$ 408.00
US$ 754.50
US$ 481.50
US$ 769.50